ZA93123B - Peptides representing fragments of CMP, antibodies directed against the said peptides, and their uses - Google Patents
Peptides representing fragments of CMP, antibodies directed against the said peptides, and their usesInfo
- Publication number
- ZA93123B ZA93123B ZA93123A ZA93123A ZA93123B ZA 93123 B ZA93123 B ZA 93123B ZA 93123 A ZA93123 A ZA 93123A ZA 93123 A ZA93123 A ZA 93123A ZA 93123 B ZA93123 B ZA 93123B
- Authority
- ZA
- South Africa
- Prior art keywords
- cmp
- peptides
- pct
- milk
- peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 239000012634 fragment Substances 0.000 title abstract 2
- 108010067454 caseinomacropeptide Proteins 0.000 abstract 5
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 235000013336 milk Nutrition 0.000 abstract 2
- 239000008267 milk Substances 0.000 abstract 2
- 210000004080 milk Anatomy 0.000 abstract 2
- 108010076119 Caseins Proteins 0.000 abstract 1
- 102000011632 Caseins Human genes 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 235000020247 cow milk Nutrition 0.000 abstract 1
- 230000009260 cross reactivity Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9200188A FR2686085B1 (fr) | 1992-01-10 | 1992-01-10 | Peptides representant des fragments du cmp, anticorps diriges contre lesdits peptides, et leurs utilisations. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA93123B true ZA93123B (en) | 1993-10-29 |
Family
ID=9425512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA93123A ZA93123B (en) | 1992-01-10 | 1993-01-08 | Peptides representing fragments of CMP, antibodies directed against the said peptides, and their uses |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5846732A (de) |
| EP (1) | EP0623145B1 (de) |
| JP (1) | JP3403406B2 (de) |
| AT (1) | ATE154807T1 (de) |
| AU (1) | AU678761B2 (de) |
| BR (1) | BR9305718A (de) |
| CA (1) | CA2127473A1 (de) |
| DE (1) | DE69311796T2 (de) |
| DK (1) | DK0623145T3 (de) |
| FI (1) | FI943218A0 (de) |
| FR (1) | FR2686085B1 (de) |
| NO (1) | NO942539L (de) |
| WO (1) | WO1993014117A1 (de) |
| ZA (1) | ZA93123B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6132712A (en) * | 1996-12-11 | 2000-10-17 | A. Glenn Braswell | Superoxide dismutase stabilized with fragments of casein and pharmaceutical compositions incorporating same |
| AUPP051497A0 (en) * | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
| US7666996B2 (en) * | 2000-03-01 | 2010-02-23 | Peptera Pharmaceuticals Ltd | Casein derived peptides and uses thereof |
| IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| JP4067349B2 (ja) * | 2002-07-02 | 2008-03-26 | 北海道 | 細菌由来凝乳酵素及び当該酵素を用いたチーズの製造 |
| AU2004298285B2 (en) * | 2003-12-19 | 2010-06-24 | Dairy Australia Limited | Antimicrobial composition |
| AU2018233588A1 (en) * | 2017-03-16 | 2019-10-31 | Microsintesis Inc. | Compositions and methods involving probiotic molecules |
| WO2018165765A1 (en) | 2017-03-16 | 2018-09-20 | Microsintesis Inc. | Propiotic molecules for reducing pathogen virulence |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3827416A1 (de) * | 1988-08-12 | 1990-02-15 | Behringwerke Ag | Peptide mit prourokinase-sequenzen, verfahren zu ihrer herstellung und ihre verwendung, antikoerper gegen diese peptide und mittel enthaltend diese antikoerper zur bestimmung von prourokinase |
| FR2646775A1 (fr) * | 1989-05-11 | 1990-11-16 | Centre Nat Rech Scient | Utilisation du caseinoglycopeptide k, notamment de lait de vache, pour la fabrication d'une composition, notamment d'un medicament, pour la prevention et le traitement des thromboses |
-
1992
- 1992-01-10 FR FR9200188A patent/FR2686085B1/fr not_active Expired - Fee Related
-
1993
- 1993-01-08 JP JP51219093A patent/JP3403406B2/ja not_active Expired - Fee Related
- 1993-01-08 DE DE69311796T patent/DE69311796T2/de not_active Expired - Fee Related
- 1993-01-08 BR BR9305718A patent/BR9305718A/pt not_active Application Discontinuation
- 1993-01-08 AT AT93914478T patent/ATE154807T1/de not_active IP Right Cessation
- 1993-01-08 ZA ZA93123A patent/ZA93123B/xx unknown
- 1993-01-08 CA CA002127473A patent/CA2127473A1/fr not_active Abandoned
- 1993-01-08 EP EP93914478A patent/EP0623145B1/de not_active Expired - Lifetime
- 1993-01-08 US US08/256,018 patent/US5846732A/en not_active Expired - Fee Related
- 1993-01-08 DK DK93914478.8T patent/DK0623145T3/da active
- 1993-01-08 AU AU34556/93A patent/AU678761B2/en not_active Ceased
- 1993-01-08 WO PCT/FR1993/000014 patent/WO1993014117A1/fr active IP Right Grant
-
1994
- 1994-07-05 FI FI943218A patent/FI943218A0/fi unknown
- 1994-07-05 NO NO942539A patent/NO942539L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2127473A1 (fr) | 1993-07-22 |
| FR2686085B1 (fr) | 1995-08-04 |
| DE69311796D1 (de) | 1997-07-31 |
| EP0623145B1 (de) | 1997-06-25 |
| NO942539D0 (no) | 1994-07-05 |
| AU3455693A (en) | 1993-08-03 |
| US5846732A (en) | 1998-12-08 |
| DE69311796T2 (de) | 1998-01-15 |
| JP3403406B2 (ja) | 2003-05-06 |
| AU678761B2 (en) | 1997-06-12 |
| NO942539L (no) | 1994-07-05 |
| FI943218A (fi) | 1994-07-05 |
| BR9305718A (pt) | 1996-12-31 |
| EP0623145A1 (de) | 1994-11-09 |
| FR2686085A1 (fr) | 1993-07-16 |
| WO1993014117A1 (fr) | 1993-07-22 |
| ATE154807T1 (de) | 1997-07-15 |
| JPH07504165A (ja) | 1995-05-11 |
| DK0623145T3 (da) | 1998-02-09 |
| FI943218A0 (fi) | 1994-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2290485A1 (en) | Method for the production of non-immunogenic proteins | |
| KR950032279A (ko) | 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna) | |
| EP0284587A3 (de) | Synthetische Peptid-Antigene für den Nachweis von HIV-1-Infektionen | |
| DE69114339T2 (de) | Verfahren zur Identifizierung oder Bestimmung von Proteinen und Verwendungen dazu. | |
| WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
| ZA93123B (en) | Peptides representing fragments of CMP, antibodies directed against the said peptides, and their uses | |
| JPS6470498A (en) | Synthetic peptide and antibody thereto | |
| EP0177814A3 (de) | Antikörper gegen Peptide und ihre Verwendung zum Nachweis von Onkogene-Produkten | |
| GB2246780B (en) | Immunodiagnostic assay for rheumatoid arthritis | |
| CA2139518C (en) | Antigenic regions of tlp complexes and antibodies against the same | |
| Endresen | Protein A reactivity of whole rabbit IgG and of fragments of rabbit IgG | |
| KR930703444A (ko) | 어류 황체화 호르몬-방출 호르몬 동족체 | |
| Coe | Specificity of antibody produced in the bullfrog (Rana catesbeiana) | |
| GB2299994B (en) | Equine arteritis virus peptides; antibodies and their use in a diagnostic test | |
| Grant et al. | Carboxy-terminal amino acid sequences of canine immunoglobulin G subclasses | |
| ZA907944B (en) | Hiv related peptides | |
| Allen et al. | An Examination of the Cross Reactivity of Human and Equine γG Globulins and Their Fragments by Immunodiffusion | |
| KR910005887A (ko) | 면역원성 물질의 고-보존된 아미노산 서열에 대한 항체, 이의 항체의 제조 방법 및 면역 감정에서의 이의 용도 | |
| ATE88639T1 (de) | Antigenisches peptid der 28kd proteingruppe aus s. mansoni und sein verfahren zur isolierung, monoklonale antikoerper, die mindestens ein epitop dieses peptids erkennen und verwendungen fuer die induzierung der synthese von neutralisierenden antikoerpern. | |
| Leung et al. | Rat Clq: Isolation and purification from normal serum and development of a sensitive hemolytic assay | |
| ES2092960A1 (es) | Gen de la proteina 1 de union a transferrina (tbp1) de actinobacillus pleuropneumoniae, utilizacion de esta en la preparacion de productos para la vacunacion contra la pleuroneumonia y en reactivos de diagnostico. | |
| CA2392423A1 (en) | Antibodies and a method for producing same, the use thereof and immunisation cocktails, immunoassay-sets and peptides |